Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biomed Oy
OY
Active
Y-tunnus 0489145-3
Sirrikuja 4B, 00940
Helsinki
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 1982
8 employees
Watchlist
Share
Finland
/
Companies
/
Manufacture of basic pharmaceutical products
/
Biomed Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
1M
2M
3M
5M
3M
2020
3M
2021
3M
2022
4M
2024
4M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2024
1M
2025
Income statement
EUR thousands
Item
2020
2021
2022
2024
2025
Revenue
2 574
2 913
3 065
3 839
4 263
Staff expenses
−334
−457
−528
−647
−709
EBITDA
146
243
138
257
692
Depreciation & amort.
−13
−6
−38
−95
−87
EBIT
134
238
100
162
605
Net financials
−7
−1
−11
−60
−47
Profit before tax
127
236
89
103
559
Tax
24
49
18
23
112
Net profit
103
187
71
80
446
Balance sheet
EUR thousands
Item
2020
2021
2022
2024
2025
Total assets
1 094
1 080
1 336
1 799
2 124
Equity
406
564
585
671
1 066
Long-term debt
295
159
241
510
327
Short-term debt
392
358
511
618
731
Total debt
687
517
752
1 128
1 059
Financial ratios
5-year trend
EBITDA margin
16.2%
This company
15.8%
Market median
+3% vs market
2020
2025
Equity ratio
50.2%
This company
38.2%
Market median
+31% vs market
2020
2025
Return on equity
41.9%
This company
18.4%
Market median
+128% vs market
2020
2025
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
2020
2025
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
2020
2025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-02-01 – 2021-01-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-02-01 – 2020-01-31
View
PDF
More on Biomed Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network